Astellas, an American a Japanese drug company, is suing a medical journal in Paris in part because it used a cartoon of a man in a silly hat to criticize one of its drugs, the eczma skin cream ...

March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...

Glenmark has received permission from the Food and Drug Administration for Tacrolimus Ointment, 0.03%, the generic of Leo Pharma's Protopic. Protopic Ointment, both 0.03% and 0.1% for adults, and only ...

July 23, 2007 (Chicago) — Children with moderate or severe atopic dermatitis can be treated less expensively over 6 weeks with 0.1% tacrolimus ointment than with 1% pimecrolimus cream, according to a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In 2006, when the FDA instilled black box warnings on ...

Perrigo announced the availability of Tacrolimus Ointment, the generic version of Astellas’ Protopic Ointment. Protopic is an immunomodulator that is indicated as second-line therapy for short-term ...

WASHINGTON — The labels on two prescription creams to treat eczema will have to bear warnings of possible cancer risks, the Food and Drug Administration said Thursday. The FDA action follows an agency ...

Protopic, the topical formulation of Astellas’ tacrolimus, has been launched in Europe for a new indication – as maintenance treatment to prevent flares and prolong flare-free intervals in adults and ...

ROCKVILLE, Md., Jan. 20 - The FDA said black box warnings about the possible risks of skin cancer and lymphoma have been added to the labels of Elidel Cream (pimecrolimus) and Protopic Ointment ...

Two eczema creams — Novartis AG’s Elidel and Fujisawa Healthcare, Inc.’s Protopic, must carry a strong warning of cancer risk, the Food and Drug Administration said Thursday. Research shows the creams ...